Dima is a Research Scientist at the Wyss Institute working closely with the Wyss Diagnostics Accelerator and the Synthetic Biology Platform. His research primarily focuses on the biology and applications of extracellular vesicles. He was previously a postdoctoral fellow and, before that, graduate student co-advised by George Church at Harvard Medical School and Aviv Regev at the Broad Institute. Before graduate school, Dima performed research at the Curie Institute in Paris and was an early employee at Exosome Diagnostics, a company developing novel liquid biopsy technologies for cancer. He has also consulted for companies and investors in the life science industry. He received a PhD in biochemistry from Harvard University, where he was a recipient of the James Mills Pierce Fellowship, and a BS in biology from MIT.